The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis K Riazi, H Azhari, JH Charette, FE Underwood, JA King, EE Afshar, ... The lancet gastroenterology & hepatology 7 (9), 851-861, 2022 | 1414 | 2022 |
Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy AM Lynn, S Singh, SE Congly, D Khemani, DH Johnson, RH Wiesner, ... Liver Transplantation 22 (6), 723-731, 2016 | 78 | 2016 |
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States AA Shaheen, HH Nguyen, SE Congly, GG Kaplan, MG Swain Liver International 39 (5), 878-884, 2019 | 65 | 2019 |
Epidemiologic burden and treatment of chronic symptomatic functional bowel disorders in the United States: a nationwide analysis C Ma, SE Congly, KL Novak, PJ Belletrutti, M Raman, M Woo, ... Gastroenterology 160 (1), 88-98. e4, 2021 | 64 | 2021 |
Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos (t) ide analogue therapy in chronic hepatitis B carriers AA Shaheen, M AlMattooq, S Yazdanfar, KW Burak, MG Swain, ... Alimentary Pharmacology & Therapeutics 46 (6), 599-604, 2017 | 61 | 2017 |
Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks SL Gares, KP Fischer, SE Congly, S Lacoste, WR Addison, DL Tyrrell, ... Clinical and vaccine immunology 13 (8), 958-965, 2006 | 61 | 2006 |
Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: Review of pathogenesis and management SF Neong, EO Billington, SE Congly Hepatology, 2018 | 53 | 2018 |
Portal vein thrombosis: should anticoagulation be used? SE Congly, SS Lee Current gastroenterology reports 15, 1-7, 2013 | 49 | 2013 |
Race and ethnicity in non-alcoholic fatty liver disease (NAFLD): a narrative review K Riazi, MG Swain, SE Congly, GG Kaplan, AA Shaheen Nutrients 14 (21), 4556, 2022 | 46 | 2022 |
Sofosbuvir-based antiviral therapy is highly effective in recurrent hepatitis C in liver transplant recipients: Canadian multicenter “real-life” experience N Faisal, M Bilodeau, B Aljudaibi, G Hirsch, EM Yoshida, T Hussaini, ... Transplantation 100 (5), 1059-1065, 2016 | 43 | 2016 |
Impact of the COVID-19 pandemic on hospitalizations for alcoholic hepatitis or cirrhosis in Alberta, Canada AA Shaheen, K Kong, C Ma, C Doktorchik, CS Coffin, MG Swain, ... Clinical Gastroenterology and Hepatology 20 (5), e1170-e1179, 2022 | 42 | 2022 |
Trends in the economic burden of chronic liver diseases and cirrhosis in the United States: 1996–2016 C Ma, AS Qian, NH Nguyen, I Stukalin, SE Congly, AA Shaheen, ... Official journal of the American College of Gastroenterology| ACG 116 (10 …, 2021 | 39 | 2021 |
Amoebic liver abscess in USA: a population‐based study of incidence, temporal trends and mortality SE Congly, AAM Shaheen, L Meddings, GG Kaplan, RP Myers Liver International 31 (8), 1191-1198, 2011 | 39 | 2011 |
Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis SE Congly, RA Varughese, CE Brown, FM Clement, L Saxinger Scientific Reports 11 (1), 17787, 2021 | 34 | 2021 |
Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network CS Coffin, A Ramji, CL Cooper, D Miles, KE Doucette, P Wong, E Tam, ... Canadian Medical Association Open Access Journal 7 (4), E610-E617, 2019 | 29 | 2019 |
Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres SE Congly, P Wong, SA Al‐Busafi, K Doucette, SK Fung, P Ghali, ... Liver International 33 (9), 1363-1369, 2013 | 29 | 2013 |
Factors associated with geographic disparities in gastrointestinal cancer mortality in the United States C Ma, SE Congly, DE Chyou, K Ross-Driscoll, N Forbes, ES Tsang, ... Gastroenterology 163 (2), 437-448. e1, 2022 | 26 | 2022 |
Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting SE Congly, AA Shaheen, MG Swain PLoS One 16 (5), e0251741, 2021 | 25 | 2021 |
Interpreting reported risks associated with use of proton pump inhibitors: residual confounding in a 10-year analysis of national ambulatory data C Ma, AA Shaheen, SE Congly, CN Andrews, P Moayyedi, N Forbes Gastroenterology 158 (3), 780-782. e3, 2020 | 25 | 2020 |
Cost‐effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk G Samadi Kochaksaraei, SE Congly, T Matwiy, E Castillo, SR Martin, ... Liver International 36 (11), 1604-1610, 2016 | 25 | 2016 |